The global Generative AI in Healthcare market is on a powerful growth trajectory. Valued at USD 2.86 billion in 2025, the market is projected to rise from USD 3.74 billion in 2026 to an impressive USD 31.51 billion by 2034, registering a compound annual growth rate (CAGR) of 30.53% during the forecast period (2026–2034).
Generative AI uses machine learning algorithms to analyze unstructured healthcare data — including patient health records, medical images, and consultation audio recordings — to improve patient outcomes and streamline clinical workflows. Its ability to parse complex genetic and molecular data for individualized treatment decisions has driven significant adoption across the healthcare industry.
Key Market Drivers
1. Product Innovation by Key Players The market is being fueled by continuous product launches. In August 2023, Codoxo introduced ClaimPilot, a generative AI product designed to enhance efficiency in healthcare cost containment and payment integrity programs.
2. Advancements in Deep Learning Progress in deep learning modules is enabling earlier and more accurate disease detection, serving as another major catalyst for market expansion.
3. COVID-19 as an Accelerator The pandemic significantly boosted adoption of generative AI solutions. During 2020–2022, healthcare providers leveraged AI tools to track patient health, assess COVID-19 symptoms, and address the mental health fallout of lockdowns. A 2023 NCBI study specifically highlighted generative AI's role in evaluating COVID-19's impact on mental health in the U.S.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/generative-artificial-intelligence-ai-in-healthcare-market-109466
Market Segmentation
By Offering
- Software — holds a dominant share, driven by major collaborations (e.g., Google Cloud partnered with Mayo Clinic in June 2023 to enhance clinical workflows using generative AI).
- Services — projected to grow at a substantial CAGR, with launches like AWS HealthScribe (Amazon Web Services, July 2023) enabling clinicians to auto-generate clinical documentation via speech recognition and AI.
By Application Electronic Health Records (EHR), Personalized Medicine, Disease Diagnosis, Drug Discovery & Development, and Others.
By End-User Hospitals & Clinics, Biopharmaceutical Companies, Diagnostic Centers, and Others.
Regional Analysis
North America leads the global market, backed by aggressive product launches from major players. A notable example: Oracle launched the Oracle Clinical Digital Assistant in September 2023 — a generative AI service integrated with EHR solutions, allowing healthcare providers to use voice commands to reduce manual documentation and improve patient outcomes.
Europe is expected to post a significant CAGR over the forecast period, propelled by strategic collaborations and partnerships between key market players and cloud/AI providers.
Key Industry Developments
- February 2024 — Persistent Systems launched a generative AI-powered population health management (PHM) solution in collaboration with Microsoft.
- August 2023 — Cognizant expanded its partnership with Google Cloud to build healthcare large language model (LLM) solutions.
- April 2023 — Microsoft deepened its collaboration with Epic Systems Corporation to integrate generative AI into EHR software via Azure OpenAI Service, targeting improved productivity and patient care.
- March 2023 — NVIDIA Corporation partnered with Medtronic to accelerate AI-based healthcare solutions and patient care innovations.
- November 2022 — Syntegra launched Syntegra Medical Mind 2.0 to advance synthetic healthcare data generation.
Key Players
The market features prominent companies including Persistent Systems, NVIDIA Corporation, Abridge AI, ELEKS, Oracle, Syntegra, Epic Systems Corporation, DiagnaMed Holdings Corp., Insilico Medicine, and Codoxo.
Conclusion
The Generative AI in Healthcare market is at an inflection point. With a 30.53% CAGR forecast through 2034, driven by deep learning advances, cloud collaborations, EHR integration, and post-pandemic digital health momentum, this sector is poised to fundamentally reshape clinical workflows, drug development, and personalized medicine at a global scale.